Rianne Remus Pulcinelli

Rianne Remus Pulcinelli

Auto-generated profile, based on publicly available information

Rianne Remus Pulcinelli

Programa de Pós-graduação em Farmacologia e Terapêutica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Toxicological Research
Verified
Journal Article
Closed access
PDF file
SBSolange Bandiera
Solange Bandiera
RPRianne R. Pulcinelli
Rianne R. Pulcinelli
FHFernanda Huf
Fernanda Huf
Felipe Borges AlmeidaFelipe Borges Almeida
Felipe Borges Almeida
GHGraziele Halmenschlager
Graziele Halmenschlager
MNMauricio S. Nin
Mauricio S. Nin

1 November 2020 in Alcohol
Verified
Journal Article
Closed access
RPRianne Remus Pulcinelli
Rianne Remus Pulcinelli
LPLeonardo Fernandes de Paula
Leonardo Fernandes de Paula
NNNatália Azuaga Nietiedt
Natália Azuaga Nietiedt
SBSolange Bandiera
Solange Bandiera
AHAlana Witt Hansen
Alana Witt Hansen
RGRosane Gomez
Rosane Gomez

1 January 2022 in Acta Amazonica
Verified
Journal Article
Open access
RPRianne Remus Pulcinelli
Rianne Remus Pulcinelli
CGClara Lindenmayer Della Giustina
Clara Lindenmayer Della Giustina
SBSolange Bandiera
Solange Bandiera
Felipe Borges AlmeidaFelipe Borges Almeida
Felipe Borges Almeida
LILucas dos Reis Izolan
Lucas dos Reis Izolan
RGRosane Gomez
Rosane Gomez
Copaiba oleoresin, extracted from the Copaifera reticulata tree, has been used as a remedy in popular medicine in the Brazilian Amazon for various purposes, including reducing drug abuse. Yet no studies evaluated the effect of repeated administration of copaiba oil on alcohol consumption in animals. To evaluate this effect, we divided adult male Wistar rats into a) an alcohol group in which the animals had free access to choose between two bottles: one containing alcohol solution (20%) and another containing vehicle solution (0.2% saccharin); and b) a control group with access to two bottles containing vehicle solution. Rats were free to drink 24 h per day, for 35 days. Daily alcohol consumption and weekly body weight gain and food intake were monitored. From day 22, half of the rats in each group received 600 mg kg-1 copaiba oleoresin and the other received vehicle, subcutaneously, once a day, for three days. On day 35, rats were evaluated in an open-field test. The results showed that copaiba oil decreased voluntary alcohol intake and preference between days 2 and 6 after the last administration. Copaiba treatment also decreased the food intake and body weight gain in both alcohol and control groups without changing behaviors in the open-field test. Therefore, copaiba oil was able to reduce voluntary alcohol consumption in rats and could be tested in humans as an adjuvant to treat alcohol use disorder.

31 October 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
GMGiovana Mezzomo
Giovana Mezzomo
TSTainá Schons
Tainá Schons
PRPedro Henrique Rosa
Pedro Henrique Rosa
PZPaola Rampelotto Ziani
Paola Rampelotto Ziani
LPLuisa Soares Pedroso
Luisa Soares Pedroso
ARAdriane R. Rosa
Adriane R. Rosa

10 July 2026 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
BSBruna Haendchen Sant'ANa
Bruna Haendchen Sant'ANa
JSJordan Silva
Jordan Silva
RPRianne Remus Pulcinelli
Rianne Remus Pulcinelli
LILucas dos Reis Izolan
Lucas dos Reis Izolan
EMEstefani Marin
Estefani Marin
RGRosane Gomez
Rosane Gomez